1、c561c 0 s e 0 l f= + u9D S K1 0 s s 0 V ?CB Z4C 1VC “ 94 0Q 9F0 HW 19F 04 ? LCerTbBC X M Su/$/ e 2v 0 s Q PB Q sS = ?E R1b 0 s 1 s8VrVCMb 0 s 0 4 S4 0 i 4 e $ MkYb1oM 0 s e M Su/$/ e 2v nQe 0 s PQJPJEUPMFSBODF Q ypD 3e)Z 0 -5 0 s uY 0eb 1 “ ?Se “5 E e .BbB Q S =R1 V ?Se 1 I n A1B b3_ M1 0 s$ “5D “5D
2、 31 0 s158 e?S bBa 0 sla “5VC#s B l S J 0 S5 GPPEBOEESVHBENJOJTUSBUJPO %“ S 0 s X H 0 O 9 geNHa INHa _ eNHa eNH r0 o DL44 HI e HW#4 1 p Hl 0 sb3 B4 HW 0 s A1Hq “5 0 s HB 2 yV A T7BMS io pC L+4 a0 HW/ 0 sA 3 N4 a N HWBC m $ 0 s?C o D$ 0 s0+l H = VCb =“5VC 0 s “5VC Z B erTh VC 0eTvh .h 9F 04 ?erT 0 r
3、wLM C“5C= “L Tvh .h C 0M1T 0a |sa _ aha B “ 0 s37vh .h 8L 3 0 s 3 0 sb s b? 0 s JOOBUFUPMFSBODF 95? 0 s nQ0VC AerT ? 0 syL.y 1b 0 s BD RVJSFEUPMFSBODF 0C 0 s / 0 0 sQ0 s? 3M 0 i/ T 1 w *“d0 i9yNbN 0 sKny 0 F y 1 0 V 1y 9 V0*) 3= l4/.%“ s8 F4 N 0 0 s#0*) (r “ -S R k 0Wi 0 s 0W9 4Bba A 0 s e 0 s “5e 3
4、 “5e /+ B 0 s “5 11 0 s$ “511 0s# X I 0 s 3oZE MBs “ E0 “5e “ 0 s -4/ E .B#4 r n58CSe4 4 B9 /$/4 0 s Q1y 0 s S441G N4e H4.eM 9 E y 9 0s y 3 .?e $ b = j 0 sE e* E M - S eEPMFZ; 0 s 4 “5D 3 A 0 sC n5E 4 b 4 “51 % n15 i 00 Ts L 0 1 .e f 4 9 3 0 sbyN 1 0 s i“ 0 9 b 0 sr VYV 9 #8 i eb “5e H E ye4 r i7C 0
5、 NC9L B.e eBC h bN He $ 5 s H .YD1“b 0 sBC S%“98C 0 sS 9 i ; e gA NHNM P 0 s “ L0b j0*)kY 0 s0*)# “5VC ) y s8/.%“ s81 “5 VC 0 rh b 0 sM1 0*) j E v4 y 9 X0*)ro Ti *h .e S H 0 l4 /.%“ s8 F4 KD4 ? X 0 s0*) ? *e1& ba 0 s e V ?C Z4C izpsb 0 sVC “5D 3 0 s 0 e b 0 s 4 S.eD Chinese Journal of Pain Medicine
6、2012 ,18 , ( 9 )0*)kY “5 n5E eC 0 l4 /.%“ s8 F4 0 s0*)erTm)b ID1 Guignard B, Bossard AE, Coste C, et al. Intraopera-tive remifentanil increases postoperative pain and morphine requirement. Anesthesiology, 2000, 93 : 409 417.2 Garzn J, Rodrguez-Muoz M, Snchez-Blzquez P. Do pharmacological approaches
7、that prevent opioid tolerance target different elements in the same regulatory machinery? Curr Drug Abuse Rev, 2008, 1 : 222 238.3 Collett BJ. Opioid tolerance: the clinical perspecti-ve. Br J Anaesth, 1998, 81 : 58 68.4 Porter J, Jick H. Addiction rare in patients treated with narcotics. Engl J Med
8、, 1980, 302 : 123.5 Albutt C. On the abuse of hypodermic injections of morphia. Practitioner, 1870, 5 : 327 331.6 Mao J, Sung B, Ji RR, et al. Chronic morphine ind-uces downregulation of spinal glutamate transport-ers: Implications in morphine tolerance and abnor-mal pain sensitivity. J Neurosci, 20
9、02, 22 : 8312 8323.7 Gardell LR, Wang R, Burgess SE, et al. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release fromm primary afferent fi bers. J Neurosci, 2002, 22 : 6747 6755.8 Vanderah TW, Suenaga NM, Ossipov MH, et al. Tonic descending f
10、acilitation from the rostral ventr-omedial medulla mediates opioid-induced abnorm-al pain and antinociceptive tolerance. J Neurosci, 2001, 21 : 279 286.9 Lotta T, Vidgren J, Tilgmann C, et al. Kinetics of human soluble and membranebound catechol O-methyltransferase: A revised mechanism and de-script
11、ion of the thermolabile variant of the enzyme. Biochemistry, 1995, 34 : 4202 4210.10 Li X, Clark JD. Hyperalgesia during opioid absti-nence: Mediation by glutamate and substance P. Anesth Analg, 2002, 95 : 979 984.11 Lee M, Silverman SM, Hansen H, et al. A comp-rehensive review of opioid-induced hyp
12、eralgesia. Pain Physician, 2011, 14 : 145 161.12 Bilsky EJ, Inturrisi CE, Sade W, et al. Competiti-ve and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain, 1996, 68 : 229 237.13 Kissin I, L
13、ee SS, Arthur GR, et al. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth Analg, 1996, 83 : 600 605.14 Elliott K, Kest B, Man A, et al.N-methyl-D-aspar-tate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic
14、 drug development. Neuropsychopharmacology, 1995, 13 : 347 356.15 Ueda H, Ueda M.Mechanisms underlying morph-ine analgesic tolerance and dependence. Front Biosci, 2009, 14 : 5260 5272.16 Jan SA. Introduction: landscape of opioid depend-ence. J Manag Care Pharm, 2010, 16 : S4 8.17 Bekhit MH. Opioid-i
15、nduced hyperalgesia and tol-erance. Am J Ther, 2010, 17 : 498 510.18 DuPen A, Shen D, Ersek M. Mechanisms of opi-oid-induced tolerance and hyperalgesia. Pain Ma-nag Nurs, 2007, 8 : 113 121.19 Foley KM. What the cancer patient has taught us. Current and emerging issues in cancer pain: rese-arch and practice. Edited by Chapman CR, Foley KM. New York: Raven Press.1993, 331 350.c565cS.eD Chinese Journal of Pain Medicine 2012 ,18 , ( 9 )
